72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

Authors: Boffito, Marta, Clayden, Polly, Peto, Tim, Pozniak, Anton, Taylor, Graham, Kambugu, Andrew, Ayabo, Tabitha, Kitaka, Sabrina Bakeera, Byakika-Kibwika, Pauline, Kiiza, Daniel, Kyohairwe, Isabella, Laker, Eva, Luswata, Andrew, Magoola, Johnson, Mayanja, Hamza, Najujuma, Flavia Vivian, Nakijoba, Ritah, Namuddu, Diana, Namuli, Teopista, Ntuyo, Peter, Onzia, Annet, Sempijja, Emmanuel, Tabwenda, Jovia, William, Baluku, Abrahams, Nina, Magano, Phakamani, Delport, Carmen, Hlwaya, Linda, Mehta, Ushma, Molitsane, Dineo, Odayar, Jasantha, Tambula, Sivuyile, Tyam, Mbuviswa, Venfolo, Olga, Allerton, Joanna, Nkonyana, Thozama, Mqaba, Sibongile, Else, Laura, Potter, Steve, Neary, Anne, Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao, Reynolds, Helen, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan, Byrne, Kelly, Seden, Kay, Twimukye, Adelline, Theunissen, Helene, Hodel, Eva Maria, Chiong, Justin, Hu, Nai-Chung, Burger, David, Wang, Duolao, Byamugisha, Josaphat, Alhassan, Yussif, Bokako, Sharon, Waitt, Catriona, Taegtmeyer, Miriam, Orrell, Catherine, Lamorde, Mohammed, Myer, Landon, Khoo, Saye ^*

Source: In The Lancet HIV August 2022 9(8):e534-e543

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

Authors: Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao, Reynolds, Helen, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan, Byrne, Kelly, Seden, Kay, Twimukye, Adelline, Theunissen, Helene, Hodel, Eva Maria, Chiong, Justin, Hu, Nai-Chung, Burger, David, Wang, Duolao, Byamugisha, Josaphat, Alhassan, Yussif, Bokako, Sharon, Waitt, Catriona, Taegtmeyer, Miriam, Orrell, Catherine, Lamorde, Mohammed, Myer, Landon, Khoo, Saye, Boffito, Marta, Clayden, Polly, Peto, Tim, Pozniak, Anton, Taylor, Graham, Kambugu, Andrew, Ayabo, Tabitha, Kitaka, Sabrina Bakeera, Byakika-Kibwika, Pauline, Kiiza, Daniel, Kyohairwe, Isabella, Laker, Eva, Luswata, Andrew, Magoola, Johnson, Mayanja, Hamza, Najujuma, Flavia Vivian, Nakijoba, Ritah, Namuddu, Diana, Namuli, Teopista, Ntuyo, Peter, Onzia, Annet, Sempijja, Emmanuel, Tabwenda, Jovia, William, Baluku, Abrahams, Nina, Magano, Phakamani, Delport, Carmen, Hlwaya, Linda, Mehta, Ushma, Molitsane, Dineo, Odayar, Jasantha, Tambula, Sivuyile, Tyam, Mbuviswa, Venfolo, Olga, Allerton, Joanna, Nkonyana, Thozama, Mqaba, Sibongile, Else, Laura, Potter, Steve, Neary, Anne

Source: The Lancet HIV; August 2022, Vol. 9 Issue: 8 pe534-e543, 10p